DividendMapper
Zimmer Biomet Holdings, Inc. logo

ZBH

Zimmer Biomet Holdings, Inc.

  • Healthcare
  • US companies in Healthcare (47)
  • NYSE · USD
  • Mkt cap $18.6bn

$97.47

as of 29 Oct 2026, 6% below its 52-week high

Screens as well placed to keep growing its dividend, with low cut-risk signals.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield
0.98%Last 12 months of regular payments at today's price
Forward yield
0.98%Each payment expected in the next 12 months, not the latest one doubled
Earnings cover
4.3×Pays 23% of earnings
Cash cover
9.7×Free cash flow over dividends paid
5y dividend growth
0.0% a yearNo cut since FY2013
Next ex-dividend date
Estimated30 Dec 2026Quarterly dividend of about $0.24

Compared with US companies in Healthcare (47)

  • Trailing yield is higher than 25 of the 46 other US companies in Healthcare.
  • 5y dividend growth (as paid) is lower than 36 of the 38 other US companies in Healthcare with a 5y growth figure.

Quality

87

High

Capacity to keep growing the dividend

Risk

0

Low

Signals of dividend-cut pressure

Trim

37

Low

How extended the valuation looks

Why Risk is 0

ZBH against US companies in Healthcare (47)

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of ZBH’s past readings.

  • P/E20.5×P17, good for this measure
  • Yield1.12%P98, good for this measure
  • FCF payout10.3%P0, good for this measure
  • Net debt / EBITDA3.02P22, good for this measure
  • DGR 5y+0.6%P32, neutral for this measure
  • ROIC5.3%P86, good for this measure
Open valuation history

Forecast your income with the ZBH dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.